Proteogenomic and metabolomic characterization of human glioblastoma

Liang-Bo Wang, Alla Karpova, Marina Gritsenko, +235

Cancer Cell

Proteogenomic Characterization of Endometrial Carcinoma

Yongchao Dou, Emily Kawaler, Daniel Cui Zhou, +214

Cell

Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer

Francesca Petralia, Nicole Tignor, Boris Reva, +141

Cell

The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance

Sunil K. Joshi, Tamilla Nechiporuk, Daniel Bottomly, +29

Cancer Cell

Residual tissue repositories as a resource for population-based cancer proteomic studies

Paul Piehowski, Vladislav Petyuk, Ryan Sontag, +13

Clinical Proteomics

Proteogenomic insights suggest druggable pathways in endometrial carcinoma

Yongchao Dou, Lizabeth Katsnelson, Marina Gritsenko, +160

Cancer Cell

Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML

Sara J.C. Gosline, Cristina E. Tognon, Michael Nestor, +17

Clinical Proteomics

Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia

James C. Pino, Camilo Posso, Sunil K. Joshi, +18

Cell Reports Medicine

The AML Microenvironment Catalyzes a Step-Wise Evolution to Gilteritinib Resistance

Sunil K. Joshi, Tamilla Nechiporuk, Daniel Bottomly, +28

SSRN Electronic Journal

Deep-Learning-Derived Evaluation Metrics Enable Effective Benchmarking of Computational Tools for Phosphopeptide Identification

Wen Jiang, Bo Wen, Kai Li, +8

Molecular & Cellular Proteomics